Phase II study of S-1 and docetaxel for previously treated patients with locally advanced or metastatic non-small cell lung cancer.
Yanagihara K, Yoshimura K, Niimi M, Yasuda H, Sasaki T, Nishimura T, Ishiguro H, Matsumoto S, Kitano T, Kanai M, Misawa A, Tada H, Teramukai S, Mio T, Fukushima M.
Yanagihara K, et al. Among authors: teramukai s.
Cancer Chemother Pharmacol. 2010 Oct;66(5):913-8. doi: 10.1007/s00280-009-1239-7. Epub 2010 Jan 13.
Cancer Chemother Pharmacol. 2010.
PMID: 20069422
Free article.
Clinical Trial.